| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.7M | +10.4% |
| Cost of Revenue | $8.3M | -0.3% |
| Gross Profit | $48.3M | +12.5% |
| R&D Expense | $11.1M | +0.0% |
| SG&A Expense | $88.5M | -3.1% |
| Operating Income | -$51.3M | +13.8% |
| Pre-tax Income | -$53.3M | +11.0% |
| Income Tax | -$18K | -132.7% |
| Net Income | -$53.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.7M | -28.5% |
| Accounts Receivable | $10.7M | +15.1% |
| Inventory | $12.2M | +0.8% |
| Current Assets | $101.6M | -21.7% |
| Total Assets | $104.8M | -21.5% |
| Current Liabilities | $13.3M | +23.7% |
| Long-term Debt | $49.5M | +0.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.2M | -2.6% |
| Capital Expenditures | $580K | -57.4% |
| Investing Cash Flow | -$580K | +57.4% |
| Financing Cash Flow | $10.5M | -81.2% |
| Free Cash Flow | -$40.8M | -0.6% |
| +11.1% |
| EPS (Basic) | -$2.04 | +23.0% |
| EPS (Diluted) | -$2.04 | +23.0% |
| Total Liabilities |
| $65.5M |
| +5.0% |
| Stockholders' Equity | $39.3M | -44.7% |